1
|
Saberi B, Gurakar A, Tamim H, Schneider CV, Sims OT, Bonder A, Fricker Z, Alqahtani SA. Racial Disparities in Candidates for Hepatocellular Carcinoma Liver Transplant After 6-Month Wait Policy Change. JAMA Netw Open 2023; 6:e2341096. [PMID: 37917059 PMCID: PMC10623194 DOI: 10.1001/jamanetworkopen.2023.41096] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/23/2023] [Accepted: 09/21/2023] [Indexed: 11/03/2023] Open
Abstract
Importance Racial disparities in liver transplant (LT) for hepatocellular carcinoma (HCC) may be associated with unequal access to life-saving treatment. Objective To quantify racial disparities in LT for HCC and mortality after LT, adjusting for demographic, clinical, and socioeconomic factors. Design, Setting, and Participants This cohort study was a retrospective analysis of United Network Organ Sharing/Organ Procurement Transplant Network (OPTN) data from 2003 to 2021. Participants were adult patients with HCC on the LT waiting list and those who received LT. Data were analyzed from March 2022 to September 2023. Exposures Race and time before and after the 2015 OPTN policy change. Main Outcomes and Measures Proportion of LT from wait-listed candidates, the proportion of waiting list removals, and mortality after LT. Results Among 12 031 patients wait-listed for LT with HCC (mean [SD] age, 60.8 [7.4] years; 9054 [75.3%] male; 7234 [60.1%] White, 2590 [21.5%] Latinx/o/a, and 1172 [9.7%] Black or African American), this study found that after the 2015 model of end-stage liver disease (MELD) exception policy changes for HCC (era 2), the overall proportion of LT for HCC across all races decreased while the proportion of dropouts on the LT waiting list remained steady compared with patients who did not have HCC. In Kaplan-Meier analysis, Asian patients demonstrated the lowest dropout rates in both era 1 and era 2 (1-year dropout, 16% and 17%, respectively; P < .001). In contrast, Black or African American patients had the highest dropout rates in era 1 (1-year dropout, 24%), but comparable dropout rates (23%) with White patients (23%) and Latinx/o/a patients in era 2 (23%). In both eras, Asian patients had the highest survival after LT (5-year survival, 82% for era 1 and 86% for era 2), while Black or African American patients had the worst survival after LT (5-year survival, 71% for era 1 and 79% for era 2). In the multivariable analysis for HCC LT recipients, Black or African American race was associated with increased risk of mortality in both eras, compared with White race (HR for era 1, 1.17; 95% CI, 1.05-1.35; and HR for era 2, 1.31; 95% CI, 1.10-1.56). Conclusions and Relevance This cohort study of LT candidates in the US found that after the 2015 MELD exception policy change for HCC, the proportion of LT for HCC had decreased for all races. Black or African American patients had worse outcomes after LT than other races. Further research is needed to identify the underlying causes of this disparity and develop strategies to improve outcomes for HCC LT candidates.
Collapse
Affiliation(s)
- Behnam Saberi
- Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts
| | - Ahmet Gurakar
- Johns Hopkins University, Division of Gastroenterology and Hepatology, Baltimore, Maryland
| | - Hani Tamim
- College of Medicine, Alfaisal University, Riyadh, Saudi Arabia
| | - Carolin V. Schneider
- Department of Internal Medicine III, Rheinisch Westfälisch Technische Hochschule Aachen University, Aachen, Germany
| | - Omar T. Sims
- Department of Gastroenterology, Hepatology and Nutrition, Cleveland Clinic, Cleveland, Ohio
- Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, Ohio
| | - Alan Bonder
- Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts
| | - Zachary Fricker
- Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts
| | - Saleh A. Alqahtani
- Johns Hopkins University, Division of Gastroenterology and Hepatology, Baltimore, Maryland
- Liver Transplant Center, King Faisal Specialist Hospital, Riyadh, Saudi Arabia
| |
Collapse
|
2
|
Payani E, Koliogiannis D, Schoenberg MB, Koch D, Eser-Valeri D, Denk G, Rehm M, Schäfer S, Ehmer U, Kremer AE, Meiser B, Werner J, Guba M, Börner N. Frequent Follow-Up of Delisted Liver Transplant Candidates Is Necessary: An Observational Study about Characteristics and Outcomes of Delisted Liver Transplant Candidates. J Clin Med 2023; 12:5880. [PMID: 37762820 PMCID: PMC10532245 DOI: 10.3390/jcm12185880] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/25/2023] [Revised: 08/27/2023] [Accepted: 09/04/2023] [Indexed: 09/29/2023] Open
Abstract
This observational study focuses on the characteristics and survival of patients taken off of the liver transplant waiting list. Assessment of post-delisting survival and a frequent follow-up of patients after delisting are important keys to improve the survival rate of patients with liver failure after being delisted. Within this study, delisted liver transplant candidates were divided into the following groups: (1) "too good" (54%) or (2) "too sick" (22%) for transplantation, (3) adherence issues (12%) or (4) therapy goal changed (11%). The 5-year survival after delisting within these groups was 84%, 9%, 50%, and 68%, respectively. Less than 3% of the delisted patients had to be relisted again. The clinical expert decision of the multidisciplinary transplant team was sufficiently accurate to differentiate between patients requiring liver transplantation and those who were delisted after a stable recovery of liver function. The assessment of post-delisting survival may serve as a complementary metric to assess differences in center practices and to estimate cumulative post-delisting mortality risk.
Collapse
Affiliation(s)
- Elnaz Payani
- Department of General-, Visceral- and Transplant Surgery, LMU University Hospital, 81377 Munich, Germany; (E.P.); (N.B.)
- Transplant Center Munich, LMU University Hospital, 81377 Munich, Germany (B.M.)
| | - Dionysios Koliogiannis
- Department of General-, Visceral- and Transplant Surgery, LMU University Hospital, 81377 Munich, Germany; (E.P.); (N.B.)
- Transplant Center Munich, LMU University Hospital, 81377 Munich, Germany (B.M.)
| | | | - Dominik Koch
- Department of General-, Visceral- and Transplant Surgery, LMU University Hospital, 81377 Munich, Germany; (E.P.); (N.B.)
- Transplant Center Munich, LMU University Hospital, 81377 Munich, Germany (B.M.)
| | | | - Gerald Denk
- Transplant Center Munich, LMU University Hospital, 81377 Munich, Germany (B.M.)
- Department of Medicine II, LMU University Hospital, 81377 Munich, Germany
| | - Markus Rehm
- Department of Anesthesiology, LMU University Hospital, 81377 Munich, Germany
| | - Simon Schäfer
- Department of Anesthesiology, LMU University Hospital, 81377 Munich, Germany
- Department of Anesthesiology, Carl von Ossietzky University Oldenburg, 26121 Oldenburg, Germany
| | - Ursula Ehmer
- Department of Medicine II, Technical University (TU) Munich Klinikum Rechts der Isar, 81675 Munich, Germany
| | - Andreas E. Kremer
- Department of Medicine I, Friedrich-Alexander University Erlangen-Nürnberg, 91054 Erlangen, Germany
- Department of Gastroenterology and Hepatology, University Hospital Zurich, Rämistrasse 100, 8091 Zürich, Switzerland
| | - Bruno Meiser
- Transplant Center Munich, LMU University Hospital, 81377 Munich, Germany (B.M.)
| | - Jens Werner
- Department of General-, Visceral- and Transplant Surgery, LMU University Hospital, 81377 Munich, Germany; (E.P.); (N.B.)
- Transplant Center Munich, LMU University Hospital, 81377 Munich, Germany (B.M.)
| | - Markus Guba
- Department of General-, Visceral- and Transplant Surgery, LMU University Hospital, 81377 Munich, Germany; (E.P.); (N.B.)
- Transplant Center Munich, LMU University Hospital, 81377 Munich, Germany (B.M.)
| | - Nikolaus Börner
- Department of General-, Visceral- and Transplant Surgery, LMU University Hospital, 81377 Munich, Germany; (E.P.); (N.B.)
- Transplant Center Munich, LMU University Hospital, 81377 Munich, Germany (B.M.)
| |
Collapse
|
3
|
Yilma M, Cogan R, Shui AM, Neuhaus JM, Light C, Braun H, Mehta N, Hirose R. Community-level social vulnerability and individual socioeconomic status on liver transplant referral outcome. Hepatol Commun 2023; 7:e00196. [PMID: 37378636 DOI: 10.1097/hc9.0000000000000196] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/13/2022] [Accepted: 05/06/2023] [Indexed: 06/29/2023] Open
Abstract
BACKGROUND Recent endeavors emphasize the importance of understanding early barriers to liver transplantation (LT) by consistently collecting data on patient demographics, socioeconomic factors, and geographic social deprivation indices. METHODS In this retrospective single-center cohort study of 1657 adults referred for LT evaluation, we assessed the association between community-level vulnerability and individual socioeconomic status measures on the rate of waitlisting and transplantation. Patients' addresses were linked to Social Vulnerability Index (SVI) at the census tract-level to characterize community-level vulnerability. Descriptive statistics were used to describe patient characteristics. Multivariable cause-specific HRs were used to assess the association between community-level vulnerability, individual measures of the socioeconomic status, and LT evaluation outcomes (waitlist and transplantation). RESULTS Among the 1657 patients referred for LT during the study period, 54% were waitlisted and 26% underwent LT. A 0.1 increase in overall SVI correlated with an 8% lower rate of waitlisting (HR 0.92, 95% CI 0.87-0.96, p < 0.001), with socioeconomic status, household characteristics, housing type and transportation, and racial and ethnic minority status domains contributing significantly to this association. Patients residing in more vulnerable communities experienced a 6% lower rate of transplantation (HR 0.94, 95% CI 0.91- 0.98, p = 0.007), with socioeconomic status and household characteristic domain of SVI significantly contributing to this association. At the individual level, both government insurance and employment status were associated with lower rates of waitlisting and transplantation. There was no association with mortality prior to waitlisting or mortality while on the waitlist. CONCLUSION Our findings indicate that both individual and community measures of the socioeconomic status (overall SVI) are associated with LT evaluation outcomes. Furthermore, we identified individual measures of neighborhood deprivation associated with both waitlisting and transplantation.
Collapse
Affiliation(s)
- Mignote Yilma
- General Surgery, University of California, San Francisco, California, USA
- National Clinician Scholars Program at the University of California, San Francisco, California, USA
| | - Raymond Cogan
- University of California, San Francisco Transplant Program, California, USA
| | - Amy M Shui
- Department of Epidemiology and Biostatistics, University of California, San Francisco, California, USA
| | - John M Neuhaus
- Department of Epidemiology and Biostatistics, University of California, San Francisco, California, USA
| | - Carolyn Light
- University of California, San Francisco Transplant Program, California, USA
| | - Hillary Braun
- General Surgery, University of California, San Francisco, California, USA
| | - Neil Mehta
- Division of Gastroenterology, University of California, San Francisco, California, USA
| | - Ryutaro Hirose
- Division of Transplant Surgery, University of California, San Francisco, California, USA
| |
Collapse
|
4
|
Yilma M, Kim NJ, Shui AM, Tana M, Landis C, Chen A, Bangaru S, Mehta N, Zhou K. Factors Associated With Liver Transplant Referral Among Patients With Cirrhosis at Multiple Safety-Net Hospitals. JAMA Netw Open 2023; 6:e2317549. [PMID: 37289453 PMCID: PMC10251211 DOI: 10.1001/jamanetworkopen.2023.17549] [Citation(s) in RCA: 5] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/22/2023] [Accepted: 04/25/2023] [Indexed: 06/09/2023] Open
Abstract
Importance A high proportion of underserved patients with cirrhosis receive care at safety-net hospitals (SNHs). While liver transplant (LT) can be a life-saving treatment for cirrhosis, data on referral patterns from SNHs to LT centers are lacking. Objective To identify factors associated with LT referral within the SNH context. Design, Setting, and Participants This retrospective cohort study included 521 adult patients with cirrhosis and model for end-stage liver disease-sodium (MELD-Na) scores of 15 or greater. Participants received outpatient hepatology care at 3 SNHs between January 1, 2016, and December 31, 2017, with end of follow-up on May 1, 2022. Exposures Patient demographic characteristics, socioeconomic status, and liver disease factors. Main Outcomes and Measures Primary outcome was referral for LT. Descriptive statistics were used to describe patient characteristics. Multivariable logistic regression was performed to evaluate factors associated with LT referral. Multiple chained imputation was used to address missing values. Results Of 521 patients, 365 (70.1%) were men, the median age was 60 (IQR, 52-66) years, most (311 [59.7%]) were Hispanic or Latinx, 338 (64.9%) had Medicaid insurance, and 427 (82.0%) had a history of alcohol use (127 [24.4%] current vs 300 [57.6%] prior). The most common liver disease etiology was alcohol associated liver disease (280 [53.7%]), followed by hepatitis C virus infection (141 [27.1%]). Median MELD-Na score was 19 (IQR, 16-22). One hundred forty-five patients (27.8%) were referred for LT. Of these, 51 (35.2%) were wait-listed, and 28 (19.3%) underwent LT. In a multivariable model, male sex (adjusted odds ratio [AOR], 0.50 [95% CI, 0.31-0.81]), Black race vs Hispanic or Latinx ethnicity (AOR, 0.19 [95% CI, 0.04-0.89]), uninsured status (AOR, 0.40 [95% CI, 0.18-0.89]), and hospital site (AOR, 0.40 [95% CI, 0.18-0.87]) were associated with lower odds of being referred. Reasons for not being referred (n = 376) included active alcohol use and/or limited sobriety (123 [32.7%]), insurance issues (80 [21.3%]), lack of social support (15 [4.0%]), undocumented status (7 [1.9%]), and unstable housing (6 [1.6%]). Conclusions In this cohort study of SNHs, less than one-third of patients with cirrhosis and MELD-Na scores of 15 or greater were referred for LT. The identified sociodemographic factors negatively associated with LT referral highlight potential intervention targets and opportunities to standardize LT referral practices to increase access to life-saving transplant among underserved patients.
Collapse
Affiliation(s)
- Mignote Yilma
- Department of General Surgery, University of California, San Francisco
- National Clinician Scholars Program, University of California, San Francisco
| | - Nicole J. Kim
- Division of Gastroenterology, University of Washington, Seattle
| | - Amy M. Shui
- Department of Epidemiology and Biostatistics, University of California, San Francisco
| | - Michele Tana
- Department of Gastroenterology and Hepatology, Zuckerberg San Francisco General Hospital, San Francisco, California
| | - Charles Landis
- Division of Gastroenterology, University of Washington, Seattle
| | - Ariana Chen
- Department of Medicine, University of Michigan, Ann Arbor
| | - Saroja Bangaru
- Division of Gastrointestinal and Liver Diseases, University of Southern California, Los Angeles
| | - Neil Mehta
- Department of Gastroenterology, University of California, San Francisco
| | - Kali Zhou
- Division of Gastrointestinal and Liver Diseases, University of Southern California, Los Angeles
| |
Collapse
|
5
|
Samuel S, Choubey A, Koizumi N, Ekwenna O, Baxter PR, Li MH, Malik R, Ortiz J. Demographic inequities exist and influence transplant outcomes in liver transplantation for acute alcohol-associated hepatitis. HPB (Oxford) 2023:S1365-182X(23)00116-8. [PMID: 37088642 DOI: 10.1016/j.hpb.2023.04.002] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/02/2023] [Revised: 04/01/2023] [Accepted: 04/05/2023] [Indexed: 04/25/2023]
Abstract
BACKGROUND Liver transplantation has inherent disparities but data is scarce in liver transplant (LT) candidates with acute alcohol-associated hepatitis (AAH). We aimed to investigate demographic inequities and its impact on survival outcomes among AAH LT candidates. METHODS A retrospective analysis using the United Network of Organ Sharing database was conducted between 2000 and 2021. 25 981 LT recipients with alcohol-associated liver cirrhosis and 662 recipients with AAH were included. Waitlisted candidates were also evaluated. RESULTS In comparison with alcohol-associated liver cirrhosis, AAH LT recipients were more likely Asian or "other" race and younger. Hispanics demonstrated better graft and patient survival (p < 0.05) but were less likely to be waitlisted and transplanted for AAH than for liver cirrhosis. Women with AAH were more likely to be waitlisted and transplanted. Pre-existing diabetes and male sex were associated with higher graft failure (25% and 8% respectively). Increasing recipient age were 2% more likely to experience negative outcomes. Chronicity of liver disease did not impact graft (p = 0.137) or patient survival (p = 0.145). CONCLUSION Our results revealed demographic factors have a significant impact on transplant listing, organ allocation and survival outcomes. Further investigations are imperative to minimize disparities in LT evaluation and provide equity in healthcare.
Collapse
Affiliation(s)
- Sonia Samuel
- Department of Internal Medicine, Albany Medical Center, Albany, NY, 12208, USA.
| | - Ankur Choubey
- Department of Surgery, Robert Wood Johnson University Hospital, New Brunswick, NJ, 08901, USA
| | - Naoru Koizumi
- Schar School of Policy and Government, George Mason University, Fairfax, VA, 22030, USA
| | - Obi Ekwenna
- Department of Urology, The University of Toledo Medical Center, Toledo, OH, 43614, USA
| | - Patrick R Baxter
- Schar School of Policy and Government, George Mason University, Fairfax, VA, 22030, USA
| | - Meng-Hao Li
- Schar School of Policy and Government, George Mason University, Fairfax, VA, 22030, USA
| | - Raza Malik
- Department of Gastroenterology and Hepatology, Albany Medical Center, Albany, NY, 12208, USA
| | - Jorge Ortiz
- Department of Surgery, Erie County Medical Center, Buffalo, NY, 14215, USA
| |
Collapse
|
6
|
McClinton A, Gullo J, Martins PN, Serrano OK. Access to liver transplantation for minority populations in the United States. Curr Opin Organ Transplant 2021; 26:508-512. [PMID: 34354000 DOI: 10.1097/mot.0000000000000904] [Citation(s) in RCA: 10] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/15/2022]
Abstract
PURPOSE OF REVIEW Racial disparities in access to liver transplantation have been known since the National Transplant Act of 1980. Since the inception of the Final Rule in 2000, the United Network of Organ Sharing has sought to ensure the equitable distribution of donor livers. Despite several measures aimed to improve access for vulnerable populations, disparities in outcomes are still prevalent throughout the liver transplant (LT) evaluation, while on the waitlist, and after liver transplantation. RECENT FINDINGS Blacks and Hispanics are underrepresented on the LT list and have an increased waitlist mortality rate compared to Whites. Additionally, Blacks have a significantly higher risk of posttransplant mortality. SUMMARY Ongoing efforts are necessary to eliminate inequities in transplant access. Strategies such as policy implementation and increasing diversity in the healthcare workforce may prove efficacious in creating change.
Collapse
Affiliation(s)
| | - Joy Gullo
- University of Connecticut School of Medicine, Farmington, Connecticut
| | - Paulo N Martins
- Department of Surgery, University of Massachusetts, Worcester, Massachusetts
| | - Oscar K Serrano
- Department of Surgery, University of Connecticut School of Medicine
- Hartford Hospital Transplant & Comprehensive Liver Center, Hartford, Connecticut, USA
| |
Collapse
|
7
|
Warren C, Carpenter AM, Neal D, Andreoni K, Sarosi G, Zarrinpar A. Racial Disparity in Liver Transplantation Listing. J Am Coll Surg 2021; 232:526-534. [PMID: 33444709 PMCID: PMC8143858 DOI: 10.1016/j.jamcollsurg.2020.12.021] [Citation(s) in RCA: 31] [Impact Index Per Article: 10.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/30/2020] [Accepted: 12/01/2020] [Indexed: 01/15/2023]
Abstract
BACKGROUND Previous studies have demonstrated disparities in transplantation for women, non-Caucasians, the uninsured or publicly insured, and rural populations. We sought to correlate transplant center characteristics with patient access to the waiting list and liver transplantation. We hypothesized that liver transplant centers vary greatly in providing equitable access to the waiting list and liver transplantation. STUDY DESIGN Center-specific, adult, deceased-donor liver transplant and waitlist data for the years 2013 to 2018 were obtained from the United Network for Organ Sharing. Waitlist race/ethnicity distributions from liver transplant centers performing ≥ 250 transplants over this period (n = 109) were compared with those of their donor service area, as calculated from 5-year US Census Bureau estimates of 2017. Center-specific characteristics correlating with disparities were analyzed using a linear regression model with a log transformed outcome. RESULTS Non-Hispanic Blacks (NHBs) are under-represented in liver transplant listing compared with center donation service area (88/109, 81%), whereas, non-Hispanic Whites are over-represented (65/109, 58%) (p < 0.0001). Hispanics were also under-represented on the waitlist at the majority of transplant centers (68/109, 62%) (p = 0.02). Although the racial/ethnic distribution of transplantation is more reflective of the waitlist, there is a higher than expected rate of transplantation for NHBs compared to the waitlist. Predictors of disparity in listing include percentage of transplant recipients at the center who had private insurance, racial composition of the donation service area, and the distance recipients had to travel for transplant. CONCLUSIONS Non-Hispanic Blacks are listed for liver transplantation less than would be expected. Once listed, however, racial disparities in transplantation are greatly diminished. Improvements in access to adequate health insurance appear to be essential to diminishing disparities in access to this life-saving care.
Collapse
Affiliation(s)
- Curtis Warren
- Department of Surgery, University of Florida, Gainesville, FL
| | | | - Daniel Neal
- Department of Surgery, University of Florida, Gainesville, FL
| | | | - George Sarosi
- Department of Surgery, University of Florida, Gainesville, FL
| | - Ali Zarrinpar
- Department of Surgery, University of Florida, Gainesville, FL.
| |
Collapse
|